Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,809
Closed -$235K 716
2025
Q1
$235K Buy
+3,809
New +$252K 0.07% 463
2024
Q4
Sell
-5,495
Closed -$448K 670
2024
Q3
$448K Buy
+5,495
New +$440K 0.17% 204
2024
Q1
Sell
-4,080
Closed -$292K 457
2023
Q4
$292K Buy
+4,080
New +$284K 0.22% 179
2023
Q3
Sell
-2,971
Closed -$241K 484
2023
Q2
$241K Sell
2,971
-3,857
-56% -$315K 0.13% 329
2023
Q1
$551K Buy
+6,828
New +$550K 0.34% 77
2022
Q3
Sell
-7,809
Closed -$541K 380
2022
Q2
$541K Buy
+7,809
New +$580K 0.6% 27

Other funds holding HOLX

Bridgefront Capital's HOLX Position: Q2 2025 in Review

Bridgefront Capital sold out of Hologic (HOLX) in Q2 2025, closing a stake of 3,809 shares — an estimated $235K sold.

Bridgefront Capital first reported a position in HOLX in Q2 2022 and held it in 6 quarters. The position peaked at $551K in Q1 2023. 692 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Bridgefront Capital reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Bridgefront Capital sold 3,809 Hologic shares in Q2 2025, an estimated $235K.
  • Bridgefront Capital first reported a position in Hologic in Q2 2022 and held it in 6 quarters.
  • Bridgefront Capital's Hologic position peaked at $551K in Q1 2023.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Bridgefront Capital's 13F filing for Q2 2025, filed 14 Aug 2025.